$NARI
Inari Medical Inc

2022 Q4 Form 10-Q Financial Statement

#000095017022021242 Filed on November 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $107.8M $96.20M
YoY Change 29.5% 31.94%
Cost Of Revenue $13.13M $11.06M
YoY Change 58.55% 57.16%
Gross Profit $94.64M $85.14M
YoY Change 26.3% 29.24%
Gross Profit Margin 87.82% 88.5%
Selling, General & Admin $79.12M $75.83M
YoY Change 47.38% 35.17%
% of Gross Profit 83.59% 89.07%
Research & Development $20.41M $19.11M
YoY Change 9.0% 52.85%
% of Gross Profit 21.57% 22.44%
Depreciation & Amortization $1.243M $1.170M
YoY Change 34.23% 42.68%
% of Gross Profit 1.31% 1.37%
Operating Expenses $100.5M $94.94M
YoY Change 37.36% 38.39%
Operating Profit -$5.891M -$9.798M
YoY Change -437.4% 259.3%
Interest Expense $896.0K $74.00K
YoY Change -1856.86% 1.37%
% of Operating Profit
Other Income/Expense, Net $187.0K $485.0K
YoY Change -1435.71% -3131.25%
Pretax Income -$4.808M -$9.313M
YoY Change -386.02% 239.52%
Income Tax $990.0K $840.0K
% Of Pretax Income
Net Earnings -$5.798M -$10.15M
YoY Change -623.76% 262.09%
Net Earnings / Revenue -5.38% -10.55%
Basic Earnings Per Share -$0.19
Diluted Earnings Per Share -$0.11 -$0.19
COMMON SHARES
Basic Shares Outstanding 53.65M 53.39M
Diluted Shares Outstanding 53.49M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $326.4M $319.2M
YoY Change 85.35% 96.34%
Cash & Equivalents $60.22M $83.53M
Short-Term Investments $266.2M $235.7M
Other Short-Term Assets $5.312M $7.609M
YoY Change -6.71% 6.55%
Inventory $32.58M $29.67M
Prepaid Expenses
Receivables $58.61M $54.06M
Other Receivables $0.00 $0.00
Total Short-Term Assets $422.9M $410.6M
YoY Change 72.47% 79.96%
LONG-TERM ASSETS
Property, Plant & Equipment $21.66M $21.19M
YoY Change 31.47% 43.69%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $8.889M $6.106M
YoY Change 806.12% 808.63%
Total Long-Term Assets $81.25M $77.25M
YoY Change 22.46% 20.18%
TOTAL ASSETS
Total Short-Term Assets $422.9M $410.6M
Total Long-Term Assets $81.25M $77.25M
Total Assets $504.2M $487.8M
YoY Change 61.82% 66.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.659M $6.035M
YoY Change 17.09% 18.73%
Accrued Expenses $48.52M $36.31M
YoY Change 34.87% 48.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $56.17M $42.34M
YoY Change 32.13% 43.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.17M $42.34M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $87.15M $72.72M
YoY Change 20.48% 25.26%
SHAREHOLDERS EQUITY
Retained Earnings -$46.85M -$41.05M
YoY Change 166.45% 119.65%
Common Stock $463.0M $457.1M
YoY Change 80.02% 80.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $417.0M $415.1M
YoY Change
Total Liabilities & Shareholders Equity $504.2M $487.8M
YoY Change 61.82% 66.82%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$5.798M -$10.15M
YoY Change -623.76% 262.09%
Depreciation, Depletion And Amortization $1.243M $1.170M
YoY Change 34.23% 42.68%
Cash From Operating Activities $11.26M -$13.07M
YoY Change -25.0% 133.78%
INVESTING ACTIVITIES
Capital Expenditures $1.778M -$2.309M
YoY Change -165.42% -51.3%
Acquisitions
YoY Change
Other Investing Activities -$31.47M $15.71M
YoY Change -51688.52% -684.7%
Cash From Investing Activities -$33.25M $13.40M
YoY Change 1151.3% -280.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.689M 3.880M
YoY Change 172.42% 29.64%
NET CHANGE
Cash From Operating Activities 11.26M -13.07M
Cash From Investing Activities -33.25M 13.40M
Cash From Financing Activities -1.689M 3.880M
Net Change In Cash -23.68M 4.216M
YoY Change -301.88% -142.06%
FREE CASH FLOW
Cash From Operating Activities $11.26M -$13.07M
Capital Expenditures $1.778M -$2.309M
Free Cash Flow $9.477M -$10.76M
YoY Change -46.53% 1168.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92752000
us-gaap Defined Benefit Plan Plan Assets Contributions By Plan Participant
DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
1.00
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5533492
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
271000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Defined Contribution Plan Tax Status Extensible List
DefinedContributionPlanTaxStatusExtensibleList
http://fasb.org/us-gaap/2022#QualifiedPlanMember
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001531048
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39293
dei Entity Registrant Name
EntityRegistrantName
Inari Medical, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2902923
dei Entity Address Address Line1
EntityAddressAddressLine1
6001 Oak Canyon
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
877
dei Local Phone Number
LocalPhoneNumber
923-4747
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
NARI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53652850
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83528000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
19000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
235705000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
83348000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54059000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42351000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Inventory Net
InventoryNet
29670000
CY2021Q4 us-gaap Inventory Net
InventoryNet
21053000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7609000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5694000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
410571000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
245198000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21191000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16471000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49951000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44909000
CY2022Q3 nari Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
6106000
CY2021Q4 nari Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
981000
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
0
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
3983000
CY2022Q3 us-gaap Assets
Assets
487819000
CY2021Q4 us-gaap Assets
Assets
311542000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6035000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6541000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28052000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24433000
CY2022Q3 nari Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
7668000
CY2021Q4 nari Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10737000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
588000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
802000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
42343000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42513000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30377000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28404000
CY2021Q4 us-gaap Liabilities
Liabilities
72333000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1416000
CY2022Q3 us-gaap Liabilities
Liabilities
72720000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53595277
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53595277
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50313452
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50313452
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
53000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
50000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
457043000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
257144000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-945000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-402000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41052000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17583000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
415099000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239209000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487819000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311542000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
96204000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72916000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
275700000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193766000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11064000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7040000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31378000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16477000
CY2022Q3 us-gaap Gross Profit
GrossProfit
85140000
CY2021Q3 us-gaap Gross Profit
GrossProfit
65876000
us-gaap Gross Profit
GrossProfit
244322000
us-gaap Gross Profit
GrossProfit
177289000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19105000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12499000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53809000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32292000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75833000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56104000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
212721000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
135899000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
94938000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
68603000
us-gaap Operating Expenses
OperatingExpenses
266530000
us-gaap Operating Expenses
OperatingExpenses
168191000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9798000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2727000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22208000
us-gaap Operating Income Loss
OperatingIncomeLoss
9098000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
618000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
27000
us-gaap Investment Income Interest
InvestmentIncomeInterest
882000
us-gaap Investment Income Interest
InvestmentIncomeInterest
130000
CY2022Q3 us-gaap Interest Expense
InterestExpense
74000
CY2021Q3 us-gaap Interest Expense
InterestExpense
73000
us-gaap Interest Expense
InterestExpense
220000
us-gaap Interest Expense
InterestExpense
220000
CY2022Q3 nari Other Income Expense
OtherIncomeExpense
-59000
CY2021Q3 nari Other Income Expense
OtherIncomeExpense
30000
nari Other Income Expense
OtherIncomeExpense
169000
nari Other Income Expense
OtherIncomeExpense
-4000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
485000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
831000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-94000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9313000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2743000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21377000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9004000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
840000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2092000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
271000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2804000
us-gaap Net Income Loss
NetIncomeLoss
-23469000
us-gaap Net Income Loss
NetIncomeLoss
8733000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-406000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-146000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-814000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-269000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
644000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
238000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-139000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-543000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-250000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9915000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2943000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24012000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8483000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53491625
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50001996
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52552662
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49664037
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53491625
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50001996
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52552662
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55511061
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239209000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
345000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3427000
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1624000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
11900000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
174394000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6555000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-365000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3129000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
418812000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
156000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1751000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7164000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-416000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10187000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
413778000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
109000
CY2022Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1224000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4995000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7356000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
238000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
415099000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
200254000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
381000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1882000
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-49000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3836000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-162000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
7469000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
213611000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193000
CY2021Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-706000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4604000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
51000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4068000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
221821000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
159000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3676000
CY2021Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-842000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12499000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-139000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2804000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
234370000
us-gaap Profit Loss
ProfitLoss
-23469000
us-gaap Profit Loss
ProfitLoss
8733000
us-gaap Depreciation
Depreciation
3430000
us-gaap Depreciation
Depreciation
2108000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
108000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
108000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1799000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
537000
us-gaap Share Based Compensation
ShareBasedCompensation
21075000
us-gaap Share Based Compensation
ShareBasedCompensation
20939000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
341000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-22000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-23000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12220000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10898000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8706000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8924000
nari Increase Decrease In Prepaid Expenses Deposits And Other Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssets
1537000
nari Increase Decrease In Prepaid Expenses Deposits And Other Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssets
4525000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-441000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2042000
nari Increase Decrease In Payroll Related Accruals Accrued Expenses And Other Liabilities
IncreaseDecreaseInPayrollRelatedAccrualsAccruedExpensesAndOtherLiabilities
-562000
nari Increase Decrease In Payroll Related Accruals Accrued Expenses And Other Liabilities
IncreaseDecreaseInPayrollRelatedAccrualsAccruedExpensesAndOtherLiabilities
12919000
nari Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-565000
nari Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-574000
nari Lease Prepayments For Lessors Owned Leasehold Improvements
LeasePrepaymentsForLessorsOwnedLeaseholdImprovements
-4503000
nari Lease Prepayments For Lessors Owned Leasehold Improvements
LeasePrepaymentsForLessorsOwnedLeaseholdImprovements
-11964000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25227000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10479000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8173000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10927000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
332103000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
105438000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
184000000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
68000000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5693000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-161969000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48365000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
11900000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
174394000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
8422000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5558000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
610000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
732000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4599000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1597000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
178827000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4693000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-855000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-266000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9224000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33459000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92752000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114617000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83528000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81158000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3085000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
271000
us-gaap Interest Paid Net
InterestPaidNet
112000
us-gaap Interest Paid Net
InterestPaidNet
113000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
2334000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
28648000
CY2022Q3 nari Fair Value Assets Level2 To Level1 Transfers Amount2
FairValueAssetsLevel2ToLevel1TransfersAmount2
0
CY2022Q3 nari Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2022Q3 nari Fair Value Liabilities Level2 To Level1 Transfers Amount2
FairValueLiabilitiesLevel2ToLevel1TransfersAmount2
0
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
276692000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
529000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management Estimates</span></p><p style="text-indent:4.133%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements may include, but are not limited to, collectability of receivables, recoverability of long-lived assets, valuation of inventory, operating lease right-of-use ("ROU") assets and liabilities, other investments, fair v</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">alue of stock options, recoverability of net deferred tax assets and related valuation allowance, and certain accruals. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. Actual results could differ materially from those estimates. Management periodically evaluates such estimates and assumptions, and they are adjusted prospectively based upon such periodic evaluation.</span></p>
CY2022Q3 us-gaap Other Investments
OtherInvestments
5700000
CY2022Q3 nari Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
281000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
276940000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
135949000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
37000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
135926000
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
626000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
285000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11700000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5763000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2691000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1490000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15279000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13800000
CY2022Q3 us-gaap Inventory Net
InventoryNet
29670000
CY2021Q4 us-gaap Inventory Net
InventoryNet
21053000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29214000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21252000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8023000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4781000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21191000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16471000
CY2020Q4 nari Operating Leases Number Of Lease Period Extension Options
OperatingLeasesNumberOfLeasePeriodExtensionOptions
2
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42200000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
28600000
CY2020Q4 nari Tenant Allowance
TenantAllowance
13500000
CY2020Q4 nari Tenant Allowance Related To Prepaid Lease Payments
TenantAllowanceRelatedToPrepaidLeasePayments
3700000
CY2020Q4 nari Prepaid Operatingleasepayments
PrepaidOperatingleasepayments
7300000
CY2020Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P226M
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061
CY2022Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
705000
CY2021Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
186000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2030000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
557000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1039000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
331000
us-gaap Operating Lease Cost
OperatingLeaseCost
3139000
us-gaap Operating Lease Cost
OperatingLeaseCost
702000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
147000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
69000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
192000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
142000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
181000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
116000
us-gaap Variable Lease Cost
VariableLeaseCost
477000
us-gaap Variable Lease Cost
VariableLeaseCost
200000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
609000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2471000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2550000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2619000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2693000
CY2022Q3 nari Lessee Operating Lease Liability Payments Thereafter
LesseeOperatingLeaseLiabilityPaymentsThereafter
41478000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
52420000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21455000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
30965000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
588000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30377000
CY2022Q3 nari Lessee Operating Lease Liability Not Yet Commenced Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityNotYetCommencedPaymentsRemainderOfFiscalYear
145000
CY2022Q3 nari Lessee Operating Lease Liability Not Yet Commenced Payments Due In Next Twelve Months
LesseeOperatingLeaseLiabilityNotYetCommencedPaymentsDueInNextTwelveMonths
758000
CY2022Q3 nari Lessee Operating Lease Liability Not Yet Commenced Payments Due Year Two
LesseeOperatingLeaseLiabilityNotYetCommencedPaymentsDueYearTwo
584000
CY2022Q3 nari Lessee Operating Lease Liability Not Yet Commenced Payments Due
LesseeOperatingLeaseLiabilityNotYetCommencedPaymentsDue
1487000
CY2022Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
29000
CY2021Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
29000
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
87000
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
87000
CY2022Q3 nari Research And Development Expense Accrued
ResearchAndDevelopmentExpenseAccrued
1200000
CY2022Q3 nari Number Of Letter Of Credit
NumberOfLetterOfCredit
4
CY2021Q4 nari Number Of Letter Of Credit
NumberOfLetterOfCredit
2
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
174400000
CY2022Q1 nari Underwriters Discounts And Commissions Expenses
UnderwritersDiscountsAndCommissionsExpenses
11200000
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
700000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7356000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12499000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21075000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20939000
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
67000000.0
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2022Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
78707
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
503135
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9313000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2743000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21377000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9004000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
840000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2092000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
271000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2804000
us-gaap Net Income Loss
NetIncomeLoss
-23469000
us-gaap Net Income Loss
NetIncomeLoss
8733000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.090
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.022
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.098
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.030
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17900000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Significant Change In Unrecognized Tax Benefits Nature Of Event
SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent
It is not expected that there will be a significant change in the uncertain tax position in the next twelve months.
us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In the normal course of business, the Company is subject to examination by tax authorities. As of the date of the financial statements, there are no income tax examinations in progress. The statute of limitations for tax years ended after December 31, 2016 and December 31, 2017 are open for state and federal tax purposes, respectively.
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1.00
CY2022Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1700000
CY2021Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6200000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2600000
us-gaap Defined Contribution Plan Increase Decrease Cost
DefinedContributionPlanIncreaseDecreaseCost
800000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2804000
us-gaap Net Income Loss
NetIncomeLoss
-23469000
us-gaap Net Income Loss
NetIncomeLoss
8733000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53491625
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50001996
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52552662
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49664037
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53491625
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50001996
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52552662
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55511061
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5533492
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5511903

Files In Submission

Name View Source Status
nari-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000950170-22-021242-index-headers.html Edgar Link pending
0000950170-22-021242-index.html Edgar Link pending
0000950170-22-021242.txt Edgar Link pending
0000950170-22-021242-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nari-20220930.htm Edgar Link pending
nari-20220930.xsd Edgar Link pending
nari-ex31_1.htm Edgar Link pending
nari-ex31_2.htm Edgar Link pending
nari-ex32_1.htm Edgar Link pending
nari-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
nari-20220930_def.xml Edgar Link unprocessable
nari-20220930_pre.xml Edgar Link unprocessable
nari-20220930_lab.xml Edgar Link unprocessable
nari-20220930_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending